Ability of circulating human hematopoietic lineage negative cells to support hematopoiesis

Pilar Peris, Matthew M. Roforth, Kristy M. Nicks, Daniel Fraser, Koji Fujita, Robert L. Jilka, Sundeep Khosla, Ulrike McGregor

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Hematopoietic stem cell (HSC) self-renewal is regulated by osteoblast and/or endothelial cells within the hematopoietic niche. However, the true identity of the supporting cells and the nature of the secreted factors remain uncertain. We developed a novel mouse model and analyzed whether circulating human peripheral hematopoietic lineage negative/AP+ (lin-/AP+) cells support hematopoiesis in vivo. Thus, immunocompromised (Rag) mice expressing thymidine kinase (Tk) under the control of the 3.6Col1α1 promoter (Tk-Rag) were treated with ganciclovir, resulting in osteoblast progenitor cell ablation and subsequent loss of hematopoiesis (evaluated by measuring mouse Ter119+ erythroid cells). Following hematopoietic cell depletion, human bone marrow-derived marrow stromal cells (MSCs) or lin-/AP+ cells were infused into Tk-Rag mice and compared with saline infusions. Ganciclovir significantly reduced (7.4-fold) Ter119+ cells in the bone marrow of Tk-Rag mice compared to saline injections. Infusion of either MSCs or lin-/AP+ cells into ganciclovir-treated mice resulted in a 3.3-fold and 2.7-fold increase (P < 0.01), respectively, in Ter119+ cells compared to mice receiving saline. Relative to lin-/AP- cells, lin-/AP+ cells expressed high levels of mesenchymal, endothelial, and hematopoiesis supporting genes. Thus, human peripheral blood lin-/AP+ cells represent a novel cell type capable of supporting hematopoiesis in a manner comparable to MSCs.

Original languageEnglish (US)
Pages (from-to)58-66
Number of pages9
JournalJournal of Cellular Biochemistry
Volume116
Issue number1
DOIs
StatePublished - Jan 1 2015

Fingerprint

Thymidine Kinase
Hematopoiesis
Ganciclovir
Osteoblasts
Bone
Cell Lineage
Stromal Cells
Bone Marrow
Endothelial cells
Ablation
Stem cells
Blood
Genes
Erythroid Cells
Hematopoietic Stem Cells
Bone Marrow Cells
Stem Cells
Endothelial Cells
Injections

Keywords

  • ENDOTHELIAL CELLS
  • HEMATOPOIESIS
  • LIN−/AP+ CELLS
  • MESENCHYMAL CELLS
  • MOUSE MODEL

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Peris, P., Roforth, M. M., Nicks, K. M., Fraser, D., Fujita, K., Jilka, R. L., ... McGregor, U. (2015). Ability of circulating human hematopoietic lineage negative cells to support hematopoiesis. Journal of Cellular Biochemistry, 116(1), 58-66. https://doi.org/10.1002/jcb.24942

Ability of circulating human hematopoietic lineage negative cells to support hematopoiesis. / Peris, Pilar; Roforth, Matthew M.; Nicks, Kristy M.; Fraser, Daniel; Fujita, Koji; Jilka, Robert L.; Khosla, Sundeep; McGregor, Ulrike.

In: Journal of Cellular Biochemistry, Vol. 116, No. 1, 01.01.2015, p. 58-66.

Research output: Contribution to journalArticle

Peris, P, Roforth, MM, Nicks, KM, Fraser, D, Fujita, K, Jilka, RL, Khosla, S & McGregor, U 2015, 'Ability of circulating human hematopoietic lineage negative cells to support hematopoiesis', Journal of Cellular Biochemistry, vol. 116, no. 1, pp. 58-66. https://doi.org/10.1002/jcb.24942
Peris, Pilar ; Roforth, Matthew M. ; Nicks, Kristy M. ; Fraser, Daniel ; Fujita, Koji ; Jilka, Robert L. ; Khosla, Sundeep ; McGregor, Ulrike. / Ability of circulating human hematopoietic lineage negative cells to support hematopoiesis. In: Journal of Cellular Biochemistry. 2015 ; Vol. 116, No. 1. pp. 58-66.
@article{becac95a0b5d4c9eba0cedd5b7892c82,
title = "Ability of circulating human hematopoietic lineage negative cells to support hematopoiesis",
abstract = "Hematopoietic stem cell (HSC) self-renewal is regulated by osteoblast and/or endothelial cells within the hematopoietic niche. However, the true identity of the supporting cells and the nature of the secreted factors remain uncertain. We developed a novel mouse model and analyzed whether circulating human peripheral hematopoietic lineage negative/AP+ (lin-/AP+) cells support hematopoiesis in vivo. Thus, immunocompromised (Rag) mice expressing thymidine kinase (Tk) under the control of the 3.6Col1α1 promoter (Tk-Rag) were treated with ganciclovir, resulting in osteoblast progenitor cell ablation and subsequent loss of hematopoiesis (evaluated by measuring mouse Ter119+ erythroid cells). Following hematopoietic cell depletion, human bone marrow-derived marrow stromal cells (MSCs) or lin-/AP+ cells were infused into Tk-Rag mice and compared with saline infusions. Ganciclovir significantly reduced (7.4-fold) Ter119+ cells in the bone marrow of Tk-Rag mice compared to saline injections. Infusion of either MSCs or lin-/AP+ cells into ganciclovir-treated mice resulted in a 3.3-fold and 2.7-fold increase (P < 0.01), respectively, in Ter119+ cells compared to mice receiving saline. Relative to lin-/AP- cells, lin-/AP+ cells expressed high levels of mesenchymal, endothelial, and hematopoiesis supporting genes. Thus, human peripheral blood lin-/AP+ cells represent a novel cell type capable of supporting hematopoiesis in a manner comparable to MSCs.",
keywords = "ENDOTHELIAL CELLS, HEMATOPOIESIS, LIN−/AP+ CELLS, MESENCHYMAL CELLS, MOUSE MODEL",
author = "Pilar Peris and Roforth, {Matthew M.} and Nicks, {Kristy M.} and Daniel Fraser and Koji Fujita and Jilka, {Robert L.} and Sundeep Khosla and Ulrike McGregor",
year = "2015",
month = "1",
day = "1",
doi = "10.1002/jcb.24942",
language = "English (US)",
volume = "116",
pages = "58--66",
journal = "Journal of Cellular Biochemistry",
issn = "0730-2312",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Ability of circulating human hematopoietic lineage negative cells to support hematopoiesis

AU - Peris, Pilar

AU - Roforth, Matthew M.

AU - Nicks, Kristy M.

AU - Fraser, Daniel

AU - Fujita, Koji

AU - Jilka, Robert L.

AU - Khosla, Sundeep

AU - McGregor, Ulrike

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Hematopoietic stem cell (HSC) self-renewal is regulated by osteoblast and/or endothelial cells within the hematopoietic niche. However, the true identity of the supporting cells and the nature of the secreted factors remain uncertain. We developed a novel mouse model and analyzed whether circulating human peripheral hematopoietic lineage negative/AP+ (lin-/AP+) cells support hematopoiesis in vivo. Thus, immunocompromised (Rag) mice expressing thymidine kinase (Tk) under the control of the 3.6Col1α1 promoter (Tk-Rag) were treated with ganciclovir, resulting in osteoblast progenitor cell ablation and subsequent loss of hematopoiesis (evaluated by measuring mouse Ter119+ erythroid cells). Following hematopoietic cell depletion, human bone marrow-derived marrow stromal cells (MSCs) or lin-/AP+ cells were infused into Tk-Rag mice and compared with saline infusions. Ganciclovir significantly reduced (7.4-fold) Ter119+ cells in the bone marrow of Tk-Rag mice compared to saline injections. Infusion of either MSCs or lin-/AP+ cells into ganciclovir-treated mice resulted in a 3.3-fold and 2.7-fold increase (P < 0.01), respectively, in Ter119+ cells compared to mice receiving saline. Relative to lin-/AP- cells, lin-/AP+ cells expressed high levels of mesenchymal, endothelial, and hematopoiesis supporting genes. Thus, human peripheral blood lin-/AP+ cells represent a novel cell type capable of supporting hematopoiesis in a manner comparable to MSCs.

AB - Hematopoietic stem cell (HSC) self-renewal is regulated by osteoblast and/or endothelial cells within the hematopoietic niche. However, the true identity of the supporting cells and the nature of the secreted factors remain uncertain. We developed a novel mouse model and analyzed whether circulating human peripheral hematopoietic lineage negative/AP+ (lin-/AP+) cells support hematopoiesis in vivo. Thus, immunocompromised (Rag) mice expressing thymidine kinase (Tk) under the control of the 3.6Col1α1 promoter (Tk-Rag) were treated with ganciclovir, resulting in osteoblast progenitor cell ablation and subsequent loss of hematopoiesis (evaluated by measuring mouse Ter119+ erythroid cells). Following hematopoietic cell depletion, human bone marrow-derived marrow stromal cells (MSCs) or lin-/AP+ cells were infused into Tk-Rag mice and compared with saline infusions. Ganciclovir significantly reduced (7.4-fold) Ter119+ cells in the bone marrow of Tk-Rag mice compared to saline injections. Infusion of either MSCs or lin-/AP+ cells into ganciclovir-treated mice resulted in a 3.3-fold and 2.7-fold increase (P < 0.01), respectively, in Ter119+ cells compared to mice receiving saline. Relative to lin-/AP- cells, lin-/AP+ cells expressed high levels of mesenchymal, endothelial, and hematopoiesis supporting genes. Thus, human peripheral blood lin-/AP+ cells represent a novel cell type capable of supporting hematopoiesis in a manner comparable to MSCs.

KW - ENDOTHELIAL CELLS

KW - HEMATOPOIESIS

KW - LIN−/AP+ CELLS

KW - MESENCHYMAL CELLS

KW - MOUSE MODEL

UR - http://www.scopus.com/inward/record.url?scp=84941117369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941117369&partnerID=8YFLogxK

U2 - 10.1002/jcb.24942

DO - 10.1002/jcb.24942

M3 - Article

C2 - 25145595

AN - SCOPUS:84941117369

VL - 116

SP - 58

EP - 66

JO - Journal of Cellular Biochemistry

JF - Journal of Cellular Biochemistry

SN - 0730-2312

IS - 1

ER -